News

Company announcements, research milestones, and field progress.

Follow updates from Upstream Biotechnology as we advance SwitchBlade-enabled crop-resilience traits through validation, partnership, and commercial development.

Media center

Press, partner, and company updates in one place.

Media inquiries

Latest updates

Recent company progress.

January 2025

Upstream Advances Tomato Disease-Resilience Program

Upstream Biotechnology is advancing tomato-focused disease-resilience work designed to combine premium quality traits with broad-spectrum disease-resistance potential.

Read about the pipeline
June 2024

Upstream initiates small-plot field trials for soybean disease-resistance trait

Field validation began for Upstream's soybean disease-resistance trait, marking a key step in advancing SwitchBlade crop-resilience programs toward partner-ready data packages.

View field-validation program
November 2023

Upstream selected for AgLaunch365 2024 cohort

Selection for AgLaunch365 strengthened Upstream's connection to farmer-focused validation, market insight, and agricultural commercialization support.

Read more
Research insight

How plants reprogram cells to fight invaders

Plant immune responses involve sophisticated changes in gene expression, cellular defense, and resource allocation. Upstream's platform is built to translate those insights into practical crop resilience.

Explore the technology

The science that got us here

Peer-reviewed research behind the platform.

Upstream's technology builds on decades of research in plant immunity, translational regulation, and the biological balance between defense and growth.

Media and partnership inquiries

For press, investors, and strategic partners.

Contact Upstream for company background, technology overview, partnership discussions, and media inquiries.

Contact Upstream